Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Pruebas
An AFP tumor marker test is a blood test that measures the level of AFP (alpha-fetoprotein) in a sample of your blood. AFP is a protein that the liver makes when its cells are growing and dividing to make new cells. AFP levels are normally high in a fetus, but after birth, they drop very low. Healthy children and adults who aren’t pregnant have very little AFP in their blood.
Artículo
Research record from Mol Diagn Ther, 2026-10-08. PMID 42848264.
Pruebas
The determination of the amount of apoptotic circulating tumor cells present in a sample.
Indicadores
This gene is involved in cellular growth regulation and is purported to have tumor suppression activity.
Artículo
Research record from Blood Cancer J, 2026-06-27. PMID 42365009.
Pruebas
A beta-2 microglobulin tumor marker test measures the amount of a protein called beta-2 microglobulin (B2M) in your body fluids. The test usually uses a sample of your blood. It may also be done using urine (pee) or in rare cases cerebrospinal fluid (CSF).
Indicadores
This anti-apoptotic gene regulates apoptotic activity. BIRC3 gene promotes tumor cell survival.
Pruebas
A BRAF genetic test uses a sample of tumor tissue, bone marrow, or blood to look for changes in a gene called BRAF . Changes in your genes are also called gene variants or mutations. The test is usually done to look for changes in the BRAF gene that may be involved in cancer .
Pruebas
An immunoassay that detects bladder cancer antigen, which is comprised of various members of the complement factor H-related protein (CFHrp) family, in urine.
Pruebas
A CA 19-9 test measures the amount of a protein called CA 19-9 (cancer antigen 19-9) in a sample of your blood. CA 19-9 is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer .
Indicadores
An antigen expressed by tissues derived from mullerian epithelium (tubal, endometrial and endocervical) or celomic epithelium (mesothelial cells of the pleura, pericardium and peritoneum). Although its biochemical nature has not been clearly defined, CA125 has been described as a glycosylated, high-molecular-weight protein that may be released from damaged cells. Measurable in plasma, CA125 is a sensitive, nonspecific tumor marker for ovarian cancer; as such it is much more useful for monitoring clinical responses to the treatment of ovarian cancer than for the diagnosis of ovarian cancer. Elevated plasma CA125 may occur in association with other malignancies and non-malignant gynecologic disorders. (NCI04)
Pruebas
This test measures the amount of a protein called CA-125 (cancer antigen 125) in a sample of your blood. CA-125 is a type of tumor marker. Tumor markers are substances that are often made by cancer cells or by normal cells in response to cancer.
